loading page

Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after 12 cycles of Venetoclax/obinutuzumab
  • +3
  • Maria Dimou,
  • Theodoros Iliakis,
  • Vasileios Pardalis,
  • Aikaterini Bitsani,
  • Marie-Christine Kyrtsonis,
  • Panayiotis Panayiotidis
Maria Dimou
National and Kapodistrian University of Athens School of Health Sciences

Corresponding Author:[email protected]

Author Profile
Theodoros Iliakis
National and Kapodistrian University of Athens School of Health Sciences
Author Profile
Vasileios Pardalis
National and Kapodistrian University of Athens School of Health Sciences
Author Profile
Aikaterini Bitsani
National and Kapodistrian University of Athens School of Health Sciences
Author Profile
Marie-Christine Kyrtsonis
National and Kapodistrian University of Athens School of Health Sciences
Author Profile
Panayiotis Panayiotidis
National and Kapodistrian University of Athens School of Health Sciences
Author Profile

Abstract

A 51-year male patient presented with large skin masses of the chest wall that were pathologically proven to be chronic lymphocytic leukemia/small lymphocytic lymphoma(CLL/SLL) with Ki67:70%. The patient was treated with the time-limited Venetoclax/Obinutuzumab combination for 12 cycles and CLL/SLL including the skin component was set in complete remission.
03 Jan 2021Submitted to Clinical Case Reports
05 Jan 2021Assigned to Editor
05 Jan 2021Submission Checks Completed
17 Jan 2021Reviewer(s) Assigned
31 May 2021Review(s) Completed, Editorial Evaluation Pending
09 Jun 2021Editorial Decision: Accept